Approval · Notice of Compliance 35283 · 2025
PMS-IVERMECTIN: Notice of Compliance 35283
Issued May 1, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35283
- Date
- May 1, 2025
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement between two manufacturers
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-IVERMECTIN | 02557363 | Marketed |
Medicinal ingredients
- IVERMECTIN 1 PER